Aug 2026· Molecules· Vol 31, pp. 2894· 0 citations· 82 references
Medicine
TL;DR
This study highlights natural diterpenoids and coumarin glycosides as promising scaffolds for caspase-1 inhibition and demonstrates that integrating QSAR modeling with structure-based approaches provides an efficient strategy for discovering potential anti-inflammatory drug candidates.
Abstract
Caspase-1 is a crucial inflammatory cysteine protease that facilitates the maturation of pro-inflammatory cytokines such as interleukin-1β and interleukin-18, making it a significant therapeutic target for inflammatory diseases. However, existing caspase-1 inhibitors often face challenges like toxicity and suboptimal drug-like properties, underscoring the need for new inhibitors. This study employed an integrated computational strategy, combining quantitative structure–activity relationship (QSAR) modeling and application of this validated model to a large natural product database followed by molecular docking, rigorous binding free energy analysis and extended molecular dynamics simulations. Initially, a dataset of 185 caspase-1 inhibitors with experimentally reported pKi values (ranging from 4.05 to 9.24) was used to construct a QSAR model using Partial Least Squares (PLS) regression. The PLS-based QSAR model was developed with 18 descriptors out of 5799 calculated descriptors for each compound and 10 latent variables, demonstrating strong statistical performance with R2 values of 0.870 and 0.838 for the training and test sets, respectively, and leave-one-out cross-validation coefficient Q2LOO and 5-fold cross-validation (Q25-fold) values of 0.819 and 0.814, respectively. Y-randomization tests further confirmed the model’s robustness, as the randomized models exhibited significantly lower statistical parameters than the original model. The validated QSAR model was applied to 276,518 natural products in the LOTUS database. Subsequent molecular docking, Molecular Mechanics/General Born Surface Area (MM/GBSA) scoring, and Pan-Assay INterference Compounds (PAINS) and Chemical Frequent Hitter (ChemFH) filtering identified 14 candidate compounds, which were further evaluated using 300 ns molecular dynamics simulations. Among these, four natural products (LTS0162325, LTS0221286, LTS0016840, and LTS0070407) showed the most stable binding behavior and maintained persistent interactions with key catalytic and substrate-binding residues of caspase-1 in a mimicked physiological condition. Overall, this study highlights natural diterpenoids and coumarin glycosides as promising scaffolds for caspase-1 inhibition and demonstrates that integrating QSAR modeling with structure-based approaches provides an efficient strategy for discovering potential anti-inflammatory drug candidates.
The findings from molecular docking, 500-ns molecular dynamics simulations, MM-GBSA calculations, and alanine scanning analyses collectively corroborate a stable binding mode of BTB11556 within the MPO active site, support further investigation of BTB11556 as a candidate compound associated with MPO-targeted therapeutic strategies.
Maysoon Raed Alnajdawi, H. Wahab, Belal Alnajjar et al.· Journal of Computer-Aided Mo...· 0 citations
Background: Chronic diabetic complications develop through the important role of aldose reductase (AR), a key enzyme in the polyol pathway. Clearly, it is important to identify potent AR inhibitors with better PK properties for treatment of diabetes-associated complications.
Purpose: The purpose of this study was to discover novel 1,3,4-thiadiazole derivatives as aldose reductase inhibitors using an integrated computational drug discovery approach.
Methods: The dataset consisted of 30 reported 1,3,4-thiadiazole derivatives, which were analysed by the pharmacophore modelling, atom-based three-dimensional quantitative structure-activity relationship (3D-QSAR), molecular docking, structure-activity relationship (SAR) analysis, R-group enumeration, virtual screening and ADMET prediction methods. Using the best pharmacophore model (AHHRR_1), a validated 3D-QSAR model was developed, and 1,419 new derivatives were designed. These compounds were then further optimised for binding interactions and pharmacokinetic parameters with the top-ranked ones, including the designed derivative PD01.
Results: The optimised pharmacophore and 3D-QSAR models were able to recognise the crucial structural elements that are essential for AR inhibition. Activity increased with the hydrophobic and electron-withdrawing groups, while the bulky polar groups were responsible for decreased activity. Docking studies showed that compounds 04 (-10.178 kcal/mol), 01 (-10.081 kcal/mol), 02 (-10.050 kcal/mol), 10 (-9.977 kcal/mol), and 11 (-9.672 kcal/mol) exhibited stronger binding than Epalrestat (-8.182 kcal/mol). The highest docking score was obtained for PD01 (-10.605 kcal/mol), which had strong hydrogen-bond, hydrophobic, π-π stacking, π-cation and halogen-bond interactions. The ADMET analysis showed good drug-likeness and good oral absorption.
Conclusion: The integrated computational workflow has concluded that PD01 is the most promising lead candidate with excellent binding affinity, a favourable interaction pattern and desirable ADMET properties. The results suggest that the scaffold 1,3,4-thiadiazole is a promising structural template for designing new generation aldose reductase inhibitors for diabetic complications.
Priya Devi, Debarshi Mondal, Shalini Sharma et al.· Journal of Pharmaceutical Te...· 0 citations
Several structurally novel compounds are identified as promising potential VEGFR2 inhibitors and supports the effectiveness of integrating pharmacophore modeling, QSAR analysis, molecular docking, and experimental validation for anticancer drug discovery.
O. Meziani, Samira Ait Kaki, F. Ferkous et al.· Journal of Computer-Aided Mo...· 0 citations
The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.
Mohd Yasir Khan, Farah Maarfi, A. Shah et al.· International Journal of Mol...· 0 citations
Findings suggest that PR1 and PR2 are promising candidates for advanced antidiabetic drug development, exhibiting predicted enhanced inhibitory activities and favorable pharmacokinetic and toxicological profiles.
L. Naanaai, Ikram Hanout, Md. Al-Amin et al.· Journal of the Iranian Chemi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.